menu
    • menu

    Company profile for Cardior Pharmaceuticals

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cardior Pharmaceuticals is a biopharmaceutical company founded in 2016 as spin-off from Medical School Hannover (MHH). The company is focused on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as innovative medicines for patients with various forms of heart failure. Within only two years Cardior Pharmaceuticals has advanced from research to clinical stage

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cardior PharmaceuticalsGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Feodor-Lynen-Str.15 30625 Hannover
    Telephone
    Telephone
    +49 (0)511-33 85 99 30
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cardior.de/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    German watchdog approves Novo's acquisition of Cardior Pharmaceuticals
    German watchdog approves Novo's acquisition of Cardior Pharmaceuticals

    19 Apr 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/german-watchdog-approves-novos-acquisition-cardior-pharmaceuticals-2024-04-18/

    REUTERS
    19 Apr 2024
    Share Share
    Novo Nordisk strikes deal worth up to $1.1 bln to expand cardio business
    Novo Nordisk strikes deal worth up to $1.1 bln to expand cardio business

    26 Mar 2024

    // REUTERS

    https://www.reuters.com/markets/deals/novo-nordisk-buy-cardior-pharmaceuticals-up-11-bln-2024-03-25/#:~:text=COPENHAGEN%2C%20March%2025%20(Reuters),to%20strengthen%20its%20cardiovascular%20pipeline.

    REUTERS
    26 Mar 2024
    Share Share
    Cardior Welcomes Dr. Orly Vardeny as Permanent Guest to the Board
    Cardior Welcomes Dr. Orly Vardeny as Permanent Guest to the Board

    01 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221201005483/en

    BUSINESSWIRE
    01 Dec 2022
    Share Share
    Cardior Announces CE Marking of CardiorHealth miR-132 PCR Kit
    Cardior Announces CE Marking of CardiorHealth miR-132 PCR Kit

    08 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220908005040/en

    BUSINESSWIRE
    08 Sep 2022
    Share Share
    Cardior Begins Dosing in PII Study of Non-coding RNA-Based Candidate CDR132L
    Cardior Begins Dosing in PII Study of Non-coding RNA-Based Candidate CDR132L

    20 Jul 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220720005435/en

    BUSINESSWIRE
    20 Jul 2022
    Share Share
    Cardior Appoints Dr. Russell Greig as Independent Chairman of the Board
    Cardior Appoints Dr. Russell Greig as Independent Chairman of the Board

    06 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220406005055/en

    BUSINESSWIRE
    06 Apr 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search